Traditional drug companies begin immunity trials

Company executives said clinical trials will be carried out on asymptomatic and suspected patients of Covid-19 to test the efficacy of immunity boosters in preventing and curing the patients. The trial results are expected to be released in about two months.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dMxCw7
via IFTTT